Pancreatic beta-cell function evaluated by intravenous glucose and glucagon stimulation. A comparison between insulin and C-peptide to measure insulin secretion

References

• Cerasi E, Luft R. The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol 1967; 55: 278–304
   PubMedGoogle Scholar
• Cerasi E, Luft R. Further studies on healthy subjects with low and high insulin response to glucose infusion. Acta Endocrinol (Copenh) 1967; 55: 305–29
   PubMedGoogle Scholar
• Ganda O P., Day J L., Soeldner J S., Connon J J., Gleason R E. Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes 1978; 27: 715–25
   PubMed Web of Science ®Google Scholar
• Smith C P., Tarn A C., Thomas J M., Overkamp D, Corakci A, Savage M O., Gale E AM. Between and within subject variation of the first phase insulin response to intravenous glucose. Diabetologia 1988; 31: 123–5
   PubMed Web of Science ®Google Scholar
• Rayman G, Clark P, Schneider A E., Hales C N. The first phase insulin response to intravenous glucose is highly reproducible. Diabetologia 1990; 33: 631–4
   PubMed Web of Science ®Google Scholar
• McCulloch D K., Klaff L J., Kahn S E., Schoenfeld S L., Greenbaum C J., Mauseth R S., Benson E A., Nepom G T., Shewey L, Palmer J P. Nonprogression of subclinical β-cell dysfunction among first-degree relatives of IDDM patients. Diabetes 1990; 39: 549–56
   PubMed Web of Science ®Google Scholar
• Vardi P, Crisa L, Jackson R A. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia 1991; 34: 93–102
   PubMed Web of Science ®Google Scholar
• Srikanta S, Ganda O P., Gleason R E., Jackson R A., Soeldner J S., Eisenbarth O S. Pre-type 1 diabetes. Linear loss of beta cell response to intravenous glucose. Diabetes 1984; 33: 717–20
   PubMed Web of Science ®Google Scholar
• Srikanta S, Ganda O P., Jackson R A., Gleason R E., Kaldany A, Garovoy M R., Milford E L., Carpenter C B., Soeldner J S., Eisenbarth G S. Type 1 diabetes mellitus in monozygotic twins: Chronic progressive beta cell dysfunction. Ann Intern Med 1983; 99: 320–6
   PubMed Web of Science ®Google Scholar
• Vialettes B, Mattei-Zcvaco C, Badicr C, Rama-Handridona G, Lassman-Vague V, Vague Ph. Low acute insulin response to intravenous glucose. A sensitive but non-specific marker of early stages of type 1 (insulin dependent) diabetes. Diabetologia 1988; 31: 592–6
   PubMed Web of Science ®Google Scholar
• Block M B., Mako M E., Steiner D F., Rubenstein A H. Circulating C-peptide immunorcactivity. Studies in normal and diabetic patients. Diabetes 1972; 21: 1013–26
   PubMed Web of Science ®Google Scholar
• Rubenstein A H., Clark J L., Melani F, Steiner D F. Secretion of proinsulin C-pcptide by pancreatic beta cells and its circulation in blood. Nature 1969; 224: 697–9
   Web of Science ®Google Scholar
• Faber O K., Binder C. C-pcptide response to glucagon. A test for the residual B-cell function in diabetes mellitus. Diabetes 1977; 26: 605–10
   PubMed Web of Science ®Google Scholar
• Koskinen P, Viikari J, Irjala K, Kaihola H-L, Seppälä P. Plasma and urinary C-peptide in the classification of adult diabetes. Scand J Clin Lab Invest 1986; 46: 655–63
   PubMed Web of Science ®Google Scholar
• Rubenstein A H., Steiner D F., Horwitz D L., Mako M E., Block M B., Starr J I., Kuzuya H, Melani F. Clinical significance of circulating proinsulin and C-peptide. Rec Progr Horm Res 1977; 33: 435–69
   Google Scholar
• Faber O K., Christensen K, Kehlet H, Madsbad S, Binder C. Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab 1981; 53: 618–21
   PubMed Web of Science ®Google Scholar
• Bonora E, Zavaroni I, Coscelli C, Butturini U. Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism 1983; 32: 438–46
   PubMed Web of Science ®Google Scholar
• Polonsky K S., Rubenstein A H. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 1984; 33: 486–94
   PubMed Web of Science ®Google Scholar
• Shapiro E T., Tillil H, Rubenstein A H., Polonsky K S. Peripheral insulin parallels changes in insulin secretion more closely than C-peptide after bolus intravenous glucose administration. J Clin Endocrinol Metab 1988; 67: 1094–9
   PubMed Web of Science ®Google Scholar
• World Health Organisation Expert Committee. Diabetes mellitus. Technical Report series no 742, GenevaSwitzerland 1985
   Google Scholar
• Jeppsson J O., Jerntorp P, Sundkvist G, Englund H, Nylund V. Measurement of hemoglobin Ale by a new liquid-chromatographic assay: metodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 1986; 32: 1867–72
   PubMed Web of Science ®Google Scholar
• Heding L S. Radioimmunological determination of C-peptide in serum. Diabetologia 1975; 11: 541–8
   PubMed Web of Science ®Google Scholar
• Thorell J I., Larsson S M. Radioimmunoassay and related techniques. C.V. Mosby Company, St. Louis 1978; 205–11
   Google Scholar
• Arnold-Larsen S, Madsbad S, Kiihl C. Reproducibility of the glucagon test. Diabetic Med 1987; 4: 299–303
   PubMed Web of Science ®Google Scholar
• Gjessing H J., Reinholdt B, Pedersen O. The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia. Diabetologia 1989; 32: 858–63
   PubMed Web of Science ®Google Scholar
• Temple R C., Carrington C A., Luzio S D., Owens D R., Schneider A E., Sobey W J., Hales C N. Insulin deficiency in non-insulin-dependent diabetes. Lancet 1989; i: 293–4
   Web of Science ®Google Scholar
• Shimokata H, Muller D C., Fleg J L., Sorkin J, Ziemba A W., Andres R. Age as independent determinant of glucose tolerance. Diabetes 1991; 40: 44–51
   PubMed Web of Science ®Google Scholar